Diamant Asset Management Inc. Purchases 296,873 Shares of Healthpeak Properties, Inc. $DOC

Diamant Asset Management Inc. raised its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 1,543.0% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 316,113 shares of the real estate investment trust’s stock after purchasing an additional 296,873 shares during the period. Diamant Asset Management Inc.’s holdings in Healthpeak Properties were worth $5,194,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in DOC. State Street Corp boosted its holdings in shares of Healthpeak Properties by 1.8% in the 3rd quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after purchasing an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Healthpeak Properties by 8.6% in the 4th quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust’s stock worth $493,251,000 after buying an additional 2,438,278 shares during the last quarter. Fuller & Thaler Asset Management Inc. boosted its stake in Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock worth $476,744,000 after buying an additional 4,776,056 shares in the last quarter. Geode Capital Management LLC boosted its stake in Healthpeak Properties by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust’s stock worth $312,959,000 after buying an additional 123,274 shares in the last quarter. Finally, Invesco Ltd. grew its position in Healthpeak Properties by 9.9% during the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust’s stock valued at $294,244,000 after acquiring an additional 1,648,012 shares during the last quarter. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

Shares of Healthpeak Properties stock opened at $21.51 on Friday. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. The business’s 50 day simple moving average is $19.06 and its two-hundred day simple moving average is $17.66. The stock has a market capitalization of $14.83 billion, a P/E ratio of 67.22, a price-to-earnings-growth ratio of 3.36 and a beta of 1.05. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $21.56.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $752.95 million during the quarter, compared to analyst estimates of $694.59 million. During the same quarter in the prior year, the firm posted $0.46 earnings per share. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Analysts forecast that Healthpeak Properties, Inc. will post 1.75 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which was paid on Friday, June 26th. Shareholders of record on Monday, June 15th were given a dividend of $0.1017 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a c) annualized dividend and a yield of 5.7%. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Analysts Set New Price Targets

Several research analysts have commented on the stock. JPMorgan Chase & Co. lifted their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a research note on Wednesday. Wells Fargo & Company upped their price objective on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a research note on Monday, June 1st. Raymond James Financial began coverage on shares of Healthpeak Properties in a report on Wednesday, June 17th. They set a “market perform” rating on the stock. Robert W. Baird lifted their target price on shares of Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Finally, Morgan Stanley reissued an “equal weight” rating and issued a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a research note on Thursday, June 11th. Three equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $19.93.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. This trade represents a 59.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.23% of the stock is currently owned by company insiders.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.